Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mega lifesciences sdn. bhd. - l-glutamine; l-isoleucine; l-leucine; l-lysine monohydrochloride; l-valine; l-arginine monohydrochloride; l-ornithine monohydrochloride -

Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mega lifesciences sdn. bhd. - soy lecithin -

Τανζανία - Αγγλικά - Tanzania Medicinces & Medical Devices Authority

mega lifesciences public company limited, thailand - mecobalamin - tablets, orodispersible - 1500

Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mega lifesciences sdn. bhd. - amylase; protease; protease; lipase; cellulase; protease; ginger root extract (zingiber officinale) -

Τανζανία - Αγγλικά - Tanzania Medicinces & Medical Devices Authority

mega lifesciences public company limited, thailand - brimonidine tartrate - eye drops - 2

Τανζανία - Αγγλικά - Tanzania Medicinces & Medical Devices Authority

mega lifesciences public company limited, thailand - rosuvastatin - film coated tablet - 10mg

Τανζανία - Αγγλικά - Tanzania Medicinces & Medical Devices Authority

mega lifesciences public company limited, thailand - rosuvastatin - film coated tablet - 20mg

Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mega lifesciences sdn. bhd. - eucalyptus globulus; zingiber officinale -

Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mega lifesciences sdn. bhd. - mentha piperita; glycyrrhiza glabra; eucalyptus globulus; bee propolis; aloe barbadensis; matricaria chamomilla; honey -

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

bryant ranch prepack - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 900 mg - -  omega-3-acid ethyl esters is indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (≥500 mg/dl) hypertriglyceridemia (htg). -  usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters and should continue this diet during treatment with omega-3-acid ethyl esters. -  laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug therapy. -  limitations of use: -  the